This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on April 18, 2025.

Return to the list of Patented Medicine Litigation page.

---

---

Rosuvastatin

CRESTOR – AstraZeneca Canada Inc. (NOC Search)

Patents:

• 2072945: RATIOPHARM, NOVOPHARM, APOTEX, SANDOZ, MYLAN, RIVA, RANBAXY, PHARMASCIENCE, COBALT, TEVA
• 2313783: RIVA, RANBAXY, PHARMASCIENCE, COBALT, TEVA, APOTEX, SANDOZ, MYLAN, RATIOPHARM
• 2315141: RANBAXY, RIVA, MYLAN

APOTEX

• Infringement – T-1562-09
• PM(NOC) – T-1972-08

COBALT

• PM(NOC) – T-780-09

MYLAN

• PM(NOC) – T-1535-10

NOVOPHARM

• Appeal – A-510-09 (2010 FCA 112)
• Infringement – T-1563-09 (2009 FC 1209)

PHARMASCIENCE

• PM(NOC) – T-528-10

RANBAXY

• PM(NOC) – T-1367-10 – T-1368-10 – T-1369-10

RATIOPHARM

• PM(NOC) – T-1694-09

RIVA

• PM(NOC) – T-1249-11 – T-1250-11

SANDOZ

• PM(NOC) – T-1074-09

TEVA

• PM(NOC) – T-1636-08 (2009 FC 1020, 2009 FC 902, 2010 FC 276)

---

Return to the Patented Medicine Litigation page.